Treatment of<unk>  has been with interferon and ribavirin. The response to treatment is similar to that in adults. It shows a similar dependence on the genotype. Recurrence after transplant is universal and the outcomes after transplant are usually poor. In<unk>  treatment should be initiated within 12 weeks of the detection of the viral RNA if viral clearance has not occurred within this time. Given the difficulties with establishing a diagnosis of hepatitis C infection in infancy, this recommendation does not apply to infants. Both pegylated interferon and ribavirin are unsuitable for use in<unk>  and infancy: newer methods of treatment are urgently required.
HCV in children and pregnancy
FACE AIDS
HIV-tainted blood scandal 
Tuberculosis in relation to HIV
HIV/AIDS in Laos
field of Hepatitis D
HIV/AIDS in Vietnam
Breastfeeding and HIV